Summit Therapeutics (SMMT) News Today $23.70 -0.72 (-2.95%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$23.81 +0.11 (+0.46%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMMT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period H.C. Wainwright Lifts PT on Summit Therapeutics (SMMT) to $50 From $44August 31 at 9:15 AM | uk.finance.yahoo.com3 No-Brainer Stocks to Buy Right NowAugust 31 at 6:45 AM | fool.comSiren L.L.C. Invests $13.41 Million in Summit Therapeutics PLC $SMMTAugust 31 at 6:29 AM | marketbeat.comHC Wainwright Has Positive Estimate for SMMT FY2026 EarningsAugust 31 at 6:15 AM | marketbeat.comRafferty Asset Management LLC Sells 81,950 Shares of Summit Therapeutics PLC $SMMTAugust 31 at 5:22 AM | marketbeat.comWhat is HC Wainwright's Forecast for SMMT FY2026 Earnings?August 31 at 2:39 AM | americanbankingnews.comSummit Therapeutics PLC $SMMT Shares Purchased by Tema Etfs LLCAugust 30 at 8:19 AM | marketbeat.comNuveen LLC Makes New $4.55 Million Investment in Summit Therapeutics PLC $SMMTAugust 29 at 3:36 AM | marketbeat.comSummit, Akeso Report Lung Cancer Survival Boost With Ivonescimab, A Rival To Merck's Keytruda Multi-Billion Dollar Franchise, Says AnalystAugust 27, 2025 | benzinga.comSummit Therapeutics price target raised to $50 from $44 at H.C. WainwrightAugust 27, 2025 | msn.comThis Is What Whales Are Betting On Summit TherapeuticsAugust 26, 2025 | benzinga.comSummit Therapeutics stock rises after Akeso reports positive trial dataAugust 26, 2025 | za.investing.comSummit Therapeutics PLC $SMMT Holdings Boosted by Russell Investments Group Ltd.August 25, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 24,355 Shares of Summit Therapeutics PLC $SMMTAugust 22, 2025 | marketbeat.comJMP Securities Reiterates Market Outperform Rating for Summit Therapeutics (NASDAQ:SMMT)August 21, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Receives Market Outperform Rating from JMP SecuritiesAugust 21, 2025 | americanbankingnews.comAnalysts Set Summit Therapeutics PLC (NASDAQ:SMMT) Price Target at $35.00August 21, 2025 | americanbankingnews.comAberdeen Group plc Sells 89,615 Shares of Summit Therapeutics PLC $SMMTAugust 20, 2025 | marketbeat.comVanguard Group Inc. Cuts Stock Position in Summit Therapeutics PLC $SMMTAugust 20, 2025 | marketbeat.comSummit draws Neutral view on risk/reward setup as Piper initiates biotech cancer namesAugust 19, 2025 | msn.comPiper starts Summit Therapeutics with Neutral on high expectationsAugust 19, 2025 | msn.comLord Abbett & CO. LLC Takes Position in Summit Therapeutics PLC (NASDAQ:SMMT)August 19, 2025 | marketbeat.comSummit Therapeutics PLC (NASDAQ:SMMT) Given Consensus Rating of "Moderate Buy" by BrokeragesAugust 19, 2025 | marketbeat.comSMMT FY2025 EPS Estimate Reduced by Cantor FitzgeraldAugust 17, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Given "Buy" Rating at HC WainwrightAugust 17, 2025 | marketbeat.com3 Fantastic Growth Stocks to Buy in AugustAugust 17, 2025 | fool.comSummit Therapeutics PLC (NASDAQ:SMMT) Stake Lessened by Deutsche Bank AGAugust 17, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Downgraded to Sell Rating by Wall Street ZenAugust 17, 2025 | marketbeat.comIvonescimab Data from Global Phase III HARMONi Study to be Showcased at Presidential Symposium at WCLC 2025August 14, 2025 | finance.yahoo.comSummit Therapeutics: Ivonescimab Data from Global Phase III HARMONi Study to be Showcased at Presidential Symposium at WCLC 2025August 14, 2025 | finanznachrichten.deSummit Therapeutics (SMMT) Nosedives 9% on Dismal Earnings, Absence of Investor CallAugust 13, 2025 | msn.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Down Following Weak EarningsAugust 13, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Price Target Raised to $34.00August 13, 2025 | marketbeat.comSummit going concern language ‘non-issue,’ says CitiAugust 13, 2025 | msn.comSummit Therapeutics (NASDAQ:SMMT) Posts Earnings Results, Misses Expectations By $0.66 EPSAugust 12, 2025 | marketbeat.comSMMT Investors Have Opportunity to Lead Summit Therapeutics Inc. Securities Fraud Lawsuit with the Schall Law FirmAugust 12, 2025 | prnewswire.comHeadlands Technologies LLC Sells 9,881 Shares of Summit Therapeutics PLC (NASDAQ:SMMT)August 12, 2025 | marketbeat.comSummit Therapeutics Reports Q2 2025 Progress and FinancialsAugust 11, 2025 | tipranks.comSMMT Investors Have Opportunity to Lead Summit Therapeutics Inc. Securities Fraud Lawsuit with the Schall Law FirmAugust 11, 2025 | businesswire.comSummit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025August 11, 2025 | businesswire.comTraders Buy Large Volume of Summit Therapeutics Call Options (NASDAQ:SMMT)August 8, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $308,000 in Summit Therapeutics PLC (NASDAQ:SMMT)August 4, 2025 | marketbeat.comTD Asset Management Inc Reduces Stock Holdings in Summit Therapeutics PLC (NASDAQ:SMMT)July 31, 2025 | marketbeat.comSummit Therapeutics (SMMT) Projected to Post Earnings on TuesdayJuly 30, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Has $1.28 Million Position in Summit Therapeutics PLC (NASDAQ:SMMT)July 30, 2025 | marketbeat.comTrivest Advisors Ltd Acquires New Position in Summit Therapeutics PLC (NASDAQ:SMMT)July 29, 2025 | marketbeat.comSummit Therapeutics Joins Elite Club Of Stocks With RS Ratings Over 90July 28, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJuly 27, 2025 | prnewswire.comIvyRock Asset Management HK Ltd Sells 74,759 Shares of Summit Therapeutics PLC (NASDAQ:SMMT)July 26, 2025 | marketbeat.comLegato Capital Management LLC Takes Position in Summit Therapeutics PLC (NASDAQ:SMMT)July 26, 2025 | marketbeat.com Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SMMT Media Mentions By Week SMMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SMMT News Sentiment▼1.101.11▲Average Medical News Sentiment SMMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SMMT Articles This Week▼148▲SMMT Articles Average Week Get the Latest News and Ratings for SMMT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Summit Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Merck & Co., Inc. News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today Insmed News Today BioNTech News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Viatris News Today Ascendis Pharma A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SMMT) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMMT Stock Alerts